{"DataElement":{"publicId":"3121376","version":"1","preferredName":"New Neoplasm Event Post Initial Therapy Indicator","preferredDefinition":"Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","longName":"3103519v1.0:2182115v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3103519","version":"1","preferredName":"New Neoplasm Event Post Initial Therapy","preferredDefinition":"New; having no previous example or precedent or parallel._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._something that happens at a given place and time._Post; occuring after._occurring at the beginning._An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","longName":"3103516v1.0:3103517v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"3103516","version":"1","preferredName":"New Neoplasm Event","preferredDefinition":"New; having no previous example or precedent or parallel.:A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.:something that happens at a given place and time.","longName":"C25586:C3262:CL052144","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"New","conceptCode":"C25586","definition":"Having no previous example or precedent or parallel; of a kind not seen before.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Event","conceptCode":"CL052144","definition":"something that happens at a given place and time.","evsSource":"NCI_META_CUI","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"879481A4-6065-72BA-E040-BB89AD4326AF","latestVersionIndicator":"Yes","beginDate":"2010-05-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-05-27","modifiedBy":"ONEDATA","dateModified":"2010-05-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3103517","version":"1","preferredName":"Post Initial Therapy","preferredDefinition":"Post; occuring after.:occurring at the beginning.:An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","longName":"C38008:CL052284:C15368","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Post","conceptCode":"C38008","definition":"Happening at a time subsequent to a reference time; later in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Initial","conceptCode":"CL052284","definition":"occurring at the beginning.","evsSource":"NCI_META_CUI","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapy","conceptCode":"C15368","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"879481A4-6077-72BA-E040-BB89AD4326AF","latestVersionIndicator":"Yes","beginDate":"2010-05-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-05-27","modifiedBy":"ONEDATA","dateModified":"2010-05-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"879481A4-6088-72BA-E040-BB89AD4326AF","latestVersionIndicator":"Yes","beginDate":"2010-05-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-05-27","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2182115","version":"1","preferredName":"Yes No Unknown Indicator","preferredDefinition":"Indicator of Yes, No, or Unknown to represent a condition.","longName":"Y_N_U_IND","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"8","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"No","valueDescription":"No ","ValueMeaning":{"publicId":"2567170","version":"1","preferredName":"No","longName":"2567170","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D36F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-13","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-13","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":"Updated to add NCIt concept relationship. Updated VM Short Name to be the Public ID to be consistent with current convention for VM Short Name - DW 10-03-2022","administrativeNotes":"2022.12.29 Alt VM added per ticket request CADSR0001837. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DCE5B97D-BF65-3072-E034-0003BA12F5E7","beginDate":"2002-03-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-06-15","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2575365","version":"1","preferredName":"Unknown","longName":"2575365","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F372-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-15","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DCE5B97D-BF66-3072-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-06-15","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Yes","valueDescription":"Yes","ValueMeaning":{"publicId":"2567168","version":"1","preferredName":"Yes","longName":"2567168","preferredDefinition":"The affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D36D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-13","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-13","modifiedBy":"GDEEN","dateModified":"2024-01-02","changeDescription":"12/29/2006 - Updated with NCI Thesaurus definition.","administrativeNotes":"2022.12.29 Alt VM added per ticket request CADSR0001837. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DCE5B97D-BF67-3072-E034-0003BA12F5E7","beginDate":"2002-07-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-06-15","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2320047","version":"1","preferredName":"Indicator","preferredDefinition":"An event, entity or condition that typically characterizes a prescribed environment or situation. Indicators determine or aid in determining whether or not certain stated circumstances exist or criteria are satisfied. (On-line Medical Dictionary)","longName":"C25180","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Indicator","conceptCode":"C25180","definition":"An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"FC6EF0D8-521A-6865-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-25","modifiedBy":"ONEDATA","dateModified":"2005-07-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D68E48B6-2CB0-46F2-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-03-26","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-03-26","modifiedBy":"REEVESD","dateModified":"2014-08-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044923","version":"1","longName":"Active CDEs as of March 2017","context":"NCIP"}]},{"publicId":"5428034","version":"1","longName":"Clinical","context":"GDC","ClassificationSchemeItems":[{"publicId":"10000695","version":"1","longName":"Diagnosis","context":"GDC"}]},{"publicId":"5655939","version":"1","longName":"BLGSP (Burkitt Lymphoma Genome Sequencing Project)","context":"OCG","ClassificationSchemeItems":[{"publicId":"10000268","version":"1","longName":"Initial Treatment and Followup Form","context":"OCG"}]},{"publicId":"7639423","version":"1","longName":"SRRS-Standardized Repository of Reference Specimens","context":"HTAN","ClassificationSchemeItems":[{"publicId":"7639047","version":"1","longName":"SRRS Clinical","context":"HTAN"}]}],"AlternateNames":[{"name":"GDC","type":"USED_BY","context":"GDC"},{"name":"progression_or_recurrence","type":"GDC_Name","context":"GDC"},{"name":"CTEP","type":"USED_BY","context":"CTEP"},{"name":"new_tumor_event_after_initial_treatment","type":"TCGA_XML_Name","context":"NCIP"},{"name":"OCG","type":"USED_BY","context":"OCG"},{"name":"HTAN","type":"USED_BY","context":"HTAN"},{"name":"progression_or_recurrence","type":"HTAN Alt Name","context":"HTAN"},{"name":"CRDC","type":"USED_BY","context":"CRDC"}],"ReferenceDocuments":[{"name":"New Tumor Event After Initial","type":"Preferred Question Text","description":"New Tumor Event After Initial Treatment","url":null,"context":"NCIP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Are there additional new malignancies that you would like to report for this reporting period","url":null,"context":"CTEP"},{"name":"CTSP Question","type":"Alternate Question Text","description":"New Tumor Event","url":null,"context":"NCIP"},{"name":"HCMI Question Text","type":"Alternate Question Text","description":"Progression?","url":null,"context":"OCG"},{"name":"HTAN Term","type":"Alternate Question Text","description":"New Neoplasm Event Post Initial Therapy Indicator","url":null,"context":"HTAN"}],"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"8B4C067D-3485-7BB3-E040-BB89AD431DD5","latestVersionIndicator":"Yes","beginDate":"2010-07-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2010-07-13","modifiedBy":"JKNABLE","dateModified":"2023-05-08","changeDescription":"3/1/22 jk Designated, added CDS alt name and CSI.  -- Curated for The Cancer Genome Atlas (TCGA) by request of J. Gardner 7/2010 mc Released per TCGA approval 8/10/2010 mc; Added alt text for CTSP task, ylu 3/27/17.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}